Status:
UNKNOWN
Biomarker Research for Personalized Medicine
Lead Sponsor:
Inje University
Conditions:
Hematologic Neoplasms
Eligibility:
All Genders
Brief Summary
The aim of this study : 1. Through the study of genes of protein, transporter, translator and epigenome investigating the effect of anti-cancer treatment or the key factor of the MDR (Multidrug resis...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Korean
- Clinical diagnosis of Hematologic neoplasms
Exclusion
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT01488591
Start Date
April 1 2009
Last Update
May 31 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inje University
Busan, South Korea, 614-735